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Abstract
The sodium ion dependent citrate transporter of Klebsiella pneumoniae (CitS) is a member of the bacterial 2-
hydroxycarboxylate transporter family. Membrane topology models of the protein, largely based on reporter molecule
fusions to C-terminally truncated CitS molecules, indicate that the protein traverses the membrane 11 times with the NH2-
terminus in the cytoplasm and the COOH-terminus in the periplasm. Furthermore, the structure is characterized by unusual
long loops in the COOH-terminal half of the protein: one hydrophobic segment between transmembrane segments V and VI
in the periplasm and three long loops connecting transmembrane segments VI and VII, VIII and IX and X and XI in the
cytoplasm. The 10 kDa biotin acceptor domain and six consecutive His residues (His-tag) were inserted at different positions
in the four long loops and the effect on transport activity and protein stability was analyzed. Six out of seven insertion
mutants were stably expressed and three of these had retained significant transport activity. The sidedness of the tags in the
mutants that tolerated the insertion was determined by proteolysis experiments. The results support the 11 transmembrane
segment model that was based upon truncated CitS proteins. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
In Klebsiella pneumoniae a unique Na dependent
citrate transporter (CitS) is induced upon anaerobic
growth on citrate [1,2]. Transport of citrate catalyzed
by CitS is strictly coupled to the uptake of two Na
ions and is driven by an electrochemical gradient of
Na ions [3^5]. The citS gene is part of an operon
that contains the genes for the enzymes of the anaer-
obic citrate degradation pathway in K. pneumoniae,
the transporter CitS, citrate lyase and the primary
Na pump, oxaloacetate decarboxylase [6]. The ami-
no acid sequence of CitS revealed that the protein is
a member of the bacterial 2-hydroxycarboxylate
transporter (2HCT) family [6]. CitS is the most dis-
tant member in the family with close to 30% se-
quence identity with the citrate and malate transport-
ers of the Gram-positive lactic acid bacteria and
two transporters of unknown function in Bacillus
subtilis.
The membrane topology of CitS has been studied
in the Escherichia coli membrane by a combination
of alkaline phosphatase (PhoA) fusions, biotin accep-
tor domain (BAD) fusions to the NH2- and COOH-
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termini, and site directed Cys labelling of the loop
between segments VIII and IX [7,8]. The folding of
CitS was studied also in the endoplasmic reticulum
membrane using in vitro translation/insertion of
C-terminally truncated CitS molecules engineered in
place of the second transmembrane segment (TMS)
of the E. coli membrane protein leader peptidase [9].
The model for the membrane topology obtained for
CitS was found to be the same in the two types of
membranes, but di¡erent from the 12 transmem-
brane helix structure common to most secondary
transporters which was also the predicted model for
CitS (Fig. 1A). In the experimental model, the CitS
protein traverses the membrane 11 times with the
NH2-terminus in the cytoplasm and the COOH-ter-
minus in the periplasm and contains a number of
long loops in the COOH-terminal half of the protein
(Fig. 1C). A strongly conserved hydrophobic stretch
of about 25 amino acid residues (segment Vb) that
was predicted to be transmembrane is situated in the
periplasm between TMSs V and VI. Three other long
loops are cytoplasmic, between TMSs VI and VII,
VIII and IX, and X and XI. The most COOH-ter-
minal loop between TMSs X and XI is the second
highly conserved region in the 2HCT family and,
even though the amino acid residues in the other
two loops are not, the length of the loops is well
conserved.
The topology model of CitS is based largely upon
C-terminal deletion mutants and, therefore, it is as-
sumed that the folding of the C-terminally truncated
proteins does not depend on C-terminal sequences.
The assumption was falsi¢ed for fusions of PhoA to
sites in the loop between TMSs VIII and IX that
resulted in a periplasmic location of the PhoA mol-
ecule (Fig. 1B). Site directed Cys labelling of cysteine
residues engineered in the same loop clearly demon-
strated that in the complete protein the loop is in the
cytoplasm [8]. In the present study another approach
was taken to bypass potential problems with the fu-
sion approach to con¢rm the membrane topology of
the C-terminal half of the protein. Tags were inserted
in the four extended loops of the CitS protein and
their sidedness was determined by proteolysis experi-
ments. Several positions in the loops were found
C
Fig. 1. Membrane topology models of CitS. (A) Predicted mod-
el based on the hydropathy pro¢le of the amino acid sequence
[7,9]. (B) Model based on C-terminal deletion PhoA fusions [7].
(C) Model based on a combination of PhoA fusions and single
Cys labelling [8,9]. Putative transmembrane segments are de-
picted as boxes and the lengths of the connecting loops are
roughly in accord with the number of residues in the loops.
Numbers indicate the position of amino acid residues. Gray
shaded loop regions represent hydrophobic stretches that were
predicted to be transmembrane. Sites for insertion of the BAD
and His-tag are depicted as circles marked ‘BAD’ and ‘HIS’, re-
spectively. The numbering of the transmembrane segments is
according to the model in C.
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which tolerated the insertion of the 10 kDa BAD of
the oxaloacetate decarboxylase of K. pneumoniae or a
sequence of six histidine residues (His-tag). These
engineered transporters showed transport activity, in-
dicating that the critical parts of the CitS moiety are
folded as in the native CitS protein. The results were
in agreement with the folding model of CitS depicted
in Fig. 1C.
2. Materials and methods
2.1. Materials
Ni2-NTA resin was obtained from Qiagen, alka-
line phosphatase (AP) labelled streptavidin from
Boehringer Mannheim, monoclonal antibodies
against AP and against the His-tag from Chemicon
International (Temecula, CA, USA) and Dianova
(Hamburg, Germany), respectively. Oligonucleotides
were obtained from Eurosequence (Groningen, The
Netherlands). The amino acid sequence of CitS is
available in the SwissProt database under accession
number P31602 and the Transport Protein Classi¢-
cation number is TC 2.24.1.1.
2.2. Bacterial strains and growth conditions
E. coli strain BL21(DE3) was routinely grown in
Luria broth (LB) medium at 37‡C. Expression of
CitS derivatives cloned in the vector pBluescript II
SK (Stratagene, La Jolla, CA, USA) was obtained
without induction. Carbenicillin was added at a ¢nal
concentration of 100 Wg/ml. Citrate transport activity
in the recombinant strains was detected as blue col-
onies on Simmons citrate agar plates (Difco). AP
activity was detected as blue colonies on LB agar
plates containing the chromogenic substrate 5-bro-
mo-4-chloro-3-indolyl-phosphate (toluidine salt ;
XP) at a concentration of 40 Wg/ml.
2.3. Genetic manipulations
Standard recombinant DNA procedures were used
essentially as described by Sambrook et al. [10]. All
the fragments obtained by PCR were sequenced after
subcloning using an Amersham automated se-
quencer.
2.3.1. Construction of BAD insertion mutants
pSBxxx
Unique NcoI sites (CCATGG) were introduced
throughout the citS gene in plasmid pSKvLCitS [7]
by site directed mutagenesis [11] which resulted in a
series of CitS-NcoI mutants described in [7] and des-
ignated pSNxxx, in which xxx refers to the residue
number of the methionine residue encoded by the
ATG codon in the introduced NcoI site. A PCR
fragment encoding the BAD of the oxaloacetate de-
carboxylase of K. pneumoniae with NcoI sites in the
£anking regions [7] was ligated into the NcoI sites of
pSN239, pSN260, pSN328, pSN389 and pSN399
yielding plasmids pSB239, pSB260, pSB328, pSB389
and pSB399, respectively.
2.3.2. Construction of His insertion mutants, pSHxxx
Two complementary oligonucleotides (5P-CATG-
CATCACCATCACCATCACGG-3P, 5P-CATGCCG-
TGATGGTGATGGTGATG-3P) were mixed and
phosphorylated in a mixture containing 5 Wl of
each primer (10 WM), 2 Wl ATP (10 mM), 2 Wl poly-
nucleotide kinase, 2 Wl 10Ukinase bu¡er and 4 Wl
H2O. The mixture was incubated at 37‡C for 1 h
followed by an incubation at 65‡C for 20 min. The
resulting stretch of double stranded DNA encoded
six histidine residues (bold; His-linker) and con-
tained at either end an overhang compatible with
an NcoI site. Subsequently, the His-linker was ligated
into the NcoI sites of pSN200 and pSN328 yielding
pSH200 and pSH328. Insertion of the linker de-
stroyed the NcoI site, which was used to screen for
positive clones. The correct orientation of the in-
serted His-tag and the reading frame were analyzed
by DNA sequencing.
2.3.3. Construction of PhoA fusions
To assay for the expression of a number of CitS
derivatives, the gene encoding mature AP was fused
at the 3P end of the citS gene. Plasmid pSA445, en-
coding CitS with the C-terminus fused to the mature
part of PhoA [7], was used to make these constructs.
A unique PstI site in the citS gene is located 160 bp
upstream of the 3P end and a unique SacI site is
located in the multiple cloning site downstream of
the citS or phoA genes. The PstI^SacI fragment of
pSA445 was isolated and ligated into pSN328,
pSB328, pSH328, pSN389 and pSB389 restricted
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with PstI and SacI, resulting in pSN328A, pSB328A,
pSH328A, pSN389A, and pSB389A, respectively.
2.4. Biochemical techniques
2.4.1. SDS^PAGE and immunoblot analysis
Cells were resuspended to an OD600 of 10, diluted
with a one-¢fth volume of loading bu¡er and boiled
for 3 min after which 5 Wl samples were loaded onto
sodium dodecyl sulfate (SDS)^polyacrylamide gels
containing 10 or 12.5% polyacrylamide. After elec-
trophoresis, the proteins were transferred to Immo-
bilon-P membranes (Millipore) by semidry electro-
phoretic blotting. PhoA fusion proteins were
detected with monoclonal antibodies directed against
PhoA, His-tagged proteins were detected with mono-
clonal anti-His-tag antibodies and biotinylated pro-
teins were detected with AP labelled streptavidin, all
at a dilution of 1:5000. Antibodies and streptavidin
were visualized using the Western-light chemilumi-
nescence detection kit with CSPD as a substrate as
recommended by the manufacturer (Tropix).
2.4.2. Preparation of ISO membranes and
spheroplasts
Cells were grown to an OD600 of 1, harvested and
washed once with 50 mM potassium phosphate pH
7, 100 mM NaCl. Inside-out (ISO) membranes were
prepared by resuspending the cells in the same bu¡er
containing 1 mM EDTA, 1 mM MgSO4 and a trace
amount of deoxyribonuclease. Cells were broken by
one passage through a French press cell operated at
10 000 psi at 4‡C and immediately mixed with a
phenylmethylsulfonyl £uoride (PMSF) solution
yielding a ¢nal concentration of 1 mM. Unbroken
cells and debris were removed by centrifugation at
14 000Ug for 10 min at 4‡C, and the ISO membranes
were collected from the supernatant by ultracentrifu-
gation at 100 000Ug for 30 min. Membranes were
washed once in 50 mM potassium phosphate pH 7
and stored in liquid nitrogen. Spheroplasts were pre-
pared essentially as described by Herzlinger et al. [12]
with modi¢cations as described in [7]. Brie£y, cells
harvested at an OD600 of 0.5 were resuspended in
10 mM Tris^HCl pH 8, 0.75 M sucrose to an
OD600 of 10 and incubated for 10 min. Lysozyme
solution was added to a ¢nal concentration of
25 Wg/ml followed by an additional 10 min of incu-
bation. The suspension was diluted three-fold in a
solution containing 1.5 mM K-EDTA and 10 mg/
ml lysozyme and incubated for 1 h at 4‡C. The
spheroplasts were harvested by centrifugation in a
tabletop centrifuge and washed once in 100 mM po-
tassium phosphate pH 7, 0.5 M sucrose and concen-
trated ¢ve times in the same bu¡er. The spheroplasts
were used immediately for the proteolytic experi-
ments.
2.4.3. Proteinase K treatment
Proteinase K was added to ISO membranes or to
spheroplasts using a freshly prepared stock solution
of 10 mg/ml. Incubation of 0.2^0.5 mg/ml ISO mem-
branes or the spheroplasts with 0.4 mg/ml proteinase
K was performed on ice and stopped after 1 h by
adding PMSF to a ¢nal concentration of 1 mM.
When indicated Triton X-100 was added at 2% con-
centration to the ISO membranes or spheroplasts
prior to the addition of proteinase K. The intactness
of the spheroplasts after proteinase K treatment was
inferred from the presence of a 22 kDa band after
immunoblotting using AP labelled streptavidin. The
22 kDa band corresponds to acetyl-CoA carboxy-
lase, the only endogenous biotinylated protein of E.
coli.
2.4.4. Ni2+-NTA puri¢cation procedure
ISO membranes (4 mg/ml) of His-tagged CitS de-
rivatives were solubilized in 50 mM potassium phos-
phate pH 8, 400 mM NaCl, 20% glycerol and 1%
Triton X-100. The solution was left on ice for 1 h
with intermittent agitation. Undissolved material was
removed by ultracentrifugation at 80 000Ug for
20 min at 4‡C. The supernatant was mixed with
Ni2-NTA resin (100 Wl per 10 mg of protein) equil-
ibrated in 50 mM potassium phosphate pH 8,
300 mM NaCl, 10% glycerol, 0.1% Triton X-100
and 20 mM imidazole and incubated for 2.5 h at
4‡C under continuous shaking and, subsequently,
poured into a column. The column was washed
with 2 ml equilibration bu¡er and, subsequently,
with 1 ml equilibration bu¡er containing 30 mM
imidazole. The protein was eluted with 2U250 Wl
of the same bu¡er containing 200 mM imidazole.
The eluate was mixed with loading bu¡er and loaded
on a 10% SDS^polyacrylamide gel that was used for
immunoblotting or stained with silver.
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3. Results
3.1. Activity and expression of NcoI mutants
In a previous study [7] a series of NcoI mutants of
CitS (SNxxx) were constructed that were used to
construct CitS^PhoA fusions. For the present study
we selected the mutants with the NcoI sites in the
regions of the citS gene encoding the long loops in
the C-terminal half of the protein. Table 1 lists the
NcoI mutants, together with the mutations in the
translated amino acid sequences. Expression of CitS
in E. coli results in citrate uptake and metabolism as
is evident from the appearance of blue halos around
colonies on Simmons agar indicator plates. Wild-
type E. coli cells exhibit a negative phenotype on
these indicator plates because of the lack of a citrate
uptake system. The ability of the NcoI mutants to
transport citrate was tested on the Simmons agar
plates. Only one of the mutants, SN328, resulted in
a negative phenotype, indicative of an inactive citrate
transport protein or lack of expression of the mutant
protein. Expression of SN328 was measured by fus-
ing the mature part of PhoA as a tag to the C-ter-
minus, yielding SN328A. The C-terminal PhoA fu-
sion of wild-type CitS (SN445A) was used as a
control [7]. Immunoblotting using antibodies against
PhoA showed a band at an apparent mass of 83 kDa
corresponding to the full length CitS^PhoA fusion
proteins, both for SN328A and for the control
(Fig. 2A) (see also [7]). A plate assay using indicator
plates to measure PhoA activity demonstrated high
PhoA activity for cells expressing SN328A, indicat-
ing a periplasmic location of the C-terminus as is the
case for the wild-type CitS protein. These observa-
tions show that CitS mutant SN328 is expressed, but
is not active. We will use the PhoA fusion assay to
determine the expression of inactive CitS derivatives
throughout this paper.
3.2. CitS^BAD insertion mutants
The N- and C-terminal NcoI mutants, SN1 and
SN445, respectively, are active and it was shown be-
fore that fusion of the BAD of the K-subunit of the
oxaloacetate decarboxylase of K. pneumoniae to ei-
ther terminus does not a¡ect activity. In vivo bio-
tinylation of the CitS^BAD fusion proteins by biotin
ligase was demonstrated using AP labelled streptavi-
din [7]. A previous study with the lactose transporter
LacY of E. coli showed that the BAD could only
successfully be inserted in cytoplasmic loops of the
protein. BAD inserted in periplasmic domains re-
mained at the cytoplasmic face of the membrane,
resulting in misfolded, inactive proteins [13]. There-
fore, in our search for catalytically active insertion
mutants, we decided to insert the BAD only in the
putative cytoplasmic loops of CitS. The BAD gene
was inserted in the NcoI site of the mutants SN239,
SN260, SN328, SN389 and SN399 resulting in
SB239, SB260, SB328, SB389 and SB399, respec-
tively. The resulting proteins have the BAD inserted
in the cytoplasmic loops between putative TMSs VI
and VII, TMSs VIII and IX and TMSs X and IX.
Table 1
Properties of CitS SNxxx mutants
Site(xxx) Loop NcoI mutations (SNxxx) BAD insertions (SBxxx) His-tag insertions (SHxxx)
Mutation Activityb Activityb Biotinylation Activityb
1a Nt T2S + + + +
200 V/VI V200M,T201A + ndc nd +
239 VI/VII W239M,L240V + 3 + nd
260 VI/VII K259T,T260M + + + nd
328 VIII/IX R327P,L328M,S329A 3 3 3 3
389 X/XI I389M + + 3 nd
399 X/XI C398S + 3 + nd
445a Ct M444T,I446V + + + +
aData from [7] and added for completeness.
bPositive phenotype on Simmons agar indicator plates.
cNot done; these insertions were not constructed.
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Insertion of the BAD in the loop between seg-
ments VI and VII at position 260 resulted in an
active CitS moiety, while insertion in the same loop
but at position 239 was not tolerated (Table 1). As
expected, insertion mutant SB328 which has the
BAD inserted in the NcoI site of the inactive
SN328 mutant, between TMSs VIII and IX, resulted
in a negative phenotype on the indicator plates. In-
sertion of the BAD in the loop between segments X
and XI resulted in CitS activity when the BAD was
inserted at position 389 while no activity could be
detected when it was inserted at position 399.
Expression and in vivo biotinylation of the inser-
tion mutants was analyzed by Western blotting of
whole cell extracts using AP labelled streptavidin
(Fig. 2B). E. coli contains one endogenous biotinyl-
ated protein, acetyl-CoA carboxylase, which results
in a 22 kDa band in all lanes. Cells expressing
SB239, SB260 and SB399 showed a strong additional
band with an apparent mass of 48 kDa (Fig. 2B,
lanes 1, 2, and 5), demonstrating that the CitS^
BAD insertion mutants were synthesized and bio-
tinylated in vivo. The size of the insertion mutants
was the same as observed for the CitS^BAD fusion
proteins SB1 and SB445 [7]. No biotinylated CitS
proteins were detected in cells expressing SB328
and SB389. The level of expression of SB328 and
SB389 was analyzed by fusing PhoA to the C-termi-
nus of both derivatives resulting in the tripartite pro-
teins SB328A and SB389A. Consistent with the ob-
served CitS activity of SB389, immunoblotting of
cells expressing SB389A revealed a band with a mo-
lecular mass of 93 kDa in agreement with the size of
the CitS^BAD^PhoA molecule (Fig. 2C, lane 2). Ap-
parently, the BAD moiety of the protein is not bio-
tinylated in vivo by biotin ligase. No fusion protein
was observed in the case of SB328A, suggesting that
insertion of the BAD at position 328 in CitS results
in unstable molecules that are rapidly degraded (Fig.
2C, lane 1).
In summary, insertion of the BAD in the loop
between TMSs VI and VII resulted in in vivo bio-
tinylated CitS that was active when the insertion was
at position 260 and inactive at position 239. Insertion
in the loop between TMSs X and XI resulted in CitS
that was active but not biotinylated when the inser-
tion was at position 389 and biotinylated but not
active when the insertion was at position 399. Inser-
tion of the BAD at position 328, between TMSs VIII
and IX, resulted in degradation of the protein (Table
1).
3.3. Sidedness of the BAD in SB260 and SB399
The active CitS^BAD fusions SB1 and SB445 al-
lowed the localization of the N- and C-termini of
Fig. 2. Western blot analysis of CitS^BAD insertion mutants. Cells expressing CitS derivatives were analyzed for alkaline phosphatase
using antibodies raised against PhoA (A, C) and biotinylation using AP labelled streptavidin (B). (A) CitS^PhoA fusions SA445 (lane
1) and SN328A (lane 2). (B) CitS^BAD insertion mutants SB239, SB260, SB328, SB389, and SB399 (lanes 1^5, respectively). (C)
CitS^BAD^PhoA insertion/fusion proteins SB328A (lane 1) and SB389A (lane 2). The arrows indicate CitS^PhoA fusion proteins
(SA), mature PhoA (PhoA), CitS^BAD insertion proteins (SB), CitS^BAD^PhoA insertion^fusion proteins (SBA) and acetyl-CoA car-
boxylase (22 kDa). Indicated at the side of the panels are the positions of the molecular size markers.
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CitS in the cytoplasm and periplasm, respectively, by
proteolysis experiments [7]. The localization of the
BAD in the CitS^BAD insertion mutants with the
BAD in the loops between segments VI and VII
(SB260) and X and XI (SB399) was determined sim-
ilarly by exposing each chimera in ISO membranes
and in spheroplasts to proteinase K. When ISO
membranes containing SB260 were treated with pro-
teinase K, a loss of the full length protein was ob-
served along with the appearance of two low molec-
ular weight bands of approximately 15 and 20 kDa
(Fig. 3A, lanes 1 and 2). In time, the 20 kDa band
was converted into the 15 kDa band that was stable
upon prolonged treatment. Proteinase K treatment
of the same ISO membranes in the presence of 2%
Triton X-100 resulted in a similar pattern with a
somewhat faster interconversion of the two bands
(Fig. 3A, lane 3). Apparently, the 15 kDa band is
resistant to proteinase K. A similar proteinase K
resistant fragment was not observed when the BAD
was fused to the N- and C-termini of CitS [7] and
when BAD was inserted at position 399 (see below),
suggesting that the BAD in SB260 is protected by
£anking CitS sequences. At any rate, the BAD in
SB260 is accessible from the cytoplasmic side of the
membrane. In the complementary experiment, treat-
ment of spheroplasts containing SB260 led to the
appearance of multiple cleavage products, (Fig. 3A,
lanes 4 and 5) suggesting that the BAD itself is not
accessible for proteinase K at the periplasmic side,
but that the CitS part is cleaved in periplasmic loops.
In the presence of 2% Triton X-100, exposure to
proteinase K resulted in the 15 kDa band, as ex-
pected (not shown). Together, the results imply that
the BAD in SB260, which is active in citrate trans-
port, is inserted in a cytoplasmic domain, in agree-
ment with the model in Fig. 1C. Similar experiments
were performed with spheroplasts of cells expressing
SB239 that was not active. The same cleavage prod-
ucts were observed as with SB260 which is consistent
with the localization of the BAD in one and the same
cytoplasmic loop (results not shown).
Proteinase K treatment of ISO membranes con-
taining SB399 with the BAD inserted in the loop
between TMSs X and XI resulted in the complete
loss of the full length fusion protein (Fig. 3B, lanes
1 and 2) and no degradation products were detected,
indicating that the BAD is accessible for proteinase
K from the cytoplasmic side of the membrane. In
agreement with this conclusion, when spheroplasts
containing SB399 were exposed to proteinase K, sta-
ble cleavage products appeared, indicating that the
BAD itself is protected by the membrane for cleav-
age (Fig. 3B, lanes 3 and 4). In SB399 (inactive) the
Fig. 3. Proteinase K digestion of SB260 (A) and SB399 (B). ISO membranes and spheroplasts prepared from E. coli BL21 (DE3) cells
expressing CitS^BAD insertion mutants SB260 and SB399 were treated with (+) and without (3) proteinase K (Prot K) and in the
presence (+) and absence (3) of Triton X-100 (TX100) as indicated. Biotinylated proteins were detected with AP labelled streptavidin.
Arrows labelled SB260 and SB399 indicate the full length insertion mutants. The arrow labelled 22 kDa indicates the acetyl-CoA car-
boxylase of E. coli. Indicated at the side of the panels are the positions of the molecular size markers.
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BAD is inserted in a cytoplasmic domain, consistent
with the topology model in Fig. 1C.
3.4. CitS^His-tag insertion mutants
A His-tag, consisting of six consecutive histidine
residues, was inserted in mutant SN200 containing
the NcoI site in the periplasmic loop between
TMSs V and VI and in SN328 containing the NcoI
site in the loop between TMSs VIII and IX that did
not accept the BAD insertion. Insertion of the His-
tag at position 200 (mutant SH200), at the end of the
hydrophobic stretch Vb, resulted in active CitS mol-
ecules (Table 1). The protein could be partially puri-
¢ed in a single step by Ni2-NTA a⁄nity chroma-
tography and detected as a band with an apparent
molecular weight of 38 kDa by SDS^PAGE which is
in agreement with the molecular mass of similar con-
structs reported before (Fig. 4A,B, lanes 1)[4]. The 38
kDa band showed reactivity with antibodies raised
against the His-tag (Fig. 4A,B, lanes 3). Some of
the impurities in the preparation represent break-
down products as is evident from the lower molec-
ular weight bands in the immunoblots. The cellular
localization of the His-tag in SH200 was determined
as described above. Proteinase K treatment of ISO
membranes resulted in the complete loss of the 38
kDa band, while a new band with a lower molecular
weight appeared (Fig. 4A, lane 2). The presence of
the His-tag at the latter protein fragment was dem-
onstrated by immunoblotting (lane 4). Apparently,
the His-tag itself is not accessible, but the CitS pro-
tein is cleaved in one or more cytoplasmic loops.
Consistent with this view is the complete loss of
any His-tagged protein when spheroplasts were
treated with proteinase K (Fig. 4B, lanes 2 and 4),
indicating that the His-tag is susceptible to cleavage
at the periplasmic side of the membrane. Together
the results clearly demonstrate that the His-tag in
active mutant SH200 has a periplasmic location, con-
sistent with the topology model based upon trun-
cated CitS molecules.
Cells expressing SH328, with the His-tag inserted
between segments VIII and IX, resulted in a very
faint band at the expected position after puri¢cation
(results not shown). In contrast to what was ob-
served with the BAD inserted at the same position,
labelling of the SH328 protein at the C-terminus with
PhoA, yielding SH328A, revealed good expression
and a periplasmic location of the C-terminus (not
shown). Apparently, the His-tag at position 328 is
not accessible to the Ni2-NTA resin.
4. Discussion
The CitS protein is believed to span the membrane
11 times with the NH2-terminus in the cytoplasm
Fig. 4. Proteinase K digestion of SH200. ISO membranes (A) and spheroplasts (B) from cells expressing His-tag insertion mutant
SH200 were incubated with (+) and without (3) proteinase K. After treatment, His-tagged proteins were partially puri¢ed by Ni2-
NTA chromatography and analyzed by silver stained SDS^PAGE (lanes 1 and 2) and by immunoblotting using monoclonal antibod-
ies directed against the His-tag (lanes 3 and 4). The full length His-tagged CitS protein and the cleaved product (A, lanes 2 and 4)
are indicated by arrows.
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and the COOH-terminus in the periplasm. The mod-
el was obtained from studies in E. coli as well as in
dog pancreas microsomes using truncated CitS mol-
ecules fused in front of a topological reporter mole-
cule [7,9]. A disadvantage of the fusion technique is
that the folding of the CitS part in the fusion protein
may be di¡erent from the folding of the same part in
the complete CitS molecule. This was evident from
PhoA fusions at sites in the loop between TMSs VIII
and IX that resulted in periplasmic PhoA, thereby
erroneously reporting the localization in the com-
plete protein (Fig. 1B). The correct localization was
determined by site directed Cys labelling techniques
[8]. In the present study tags were inserted in loops of
CitS and their sidedness with respect to the mem-
brane supports certain aspects of the model in Fig.
1C. The sidedness of the tags was determined for
those insertion mutants that tolerated the insertion
by showing citrate transport activity (SH200, SB260)
or, at least, resulted in a stable CitS derivative
(SB399). Moreover, in the latter construct, a C-ter-
minal PhoA fusion of SB399 showed that the C-ter-
minus was correctly located in the periplasm (not
shown). It is assumed that the structure of CitS is
not severely disrupted in these constructs. Proteolytic
experiments with constructs in which a His-tag was
inserted in the periplasmic loop between segments V
and VI (SH200) and the BAD inserted in the loop
between segments VI and VII (SB260) con¢rmed the
periplasmic and cytoplasmic location of the loops,
respectively. Similarly, the cytoplasmic location of
the loop in between segments X and XI was con-
¢rmed in construct SB399. A CitS molecule with
the BAD inserted 10 residues upstream at position
389 (SB389) showed citrate transport activity, indi-
cating correct folding of the CitS moiety. Insertion of
the BAD in periplasmic domains of LacY of E. coli
was shown to result in misfolded, inactive transport-
er molecules [13]. Therefore, it is likely that the BAD
in SB389 is in a cytoplasmic domain and that the
lack of in vivo biotinylation is due to the inaccessi-
bility of the biotinylation site to the biotin ligase.
The common architecture of bacterial secondary
transporters is a bundle of transmembrane K-helices
that are connected by, usually, short hydrophilic
loops. The hydrophilic loops in a membrane protein
may be very £exible with their main function being
to connect the TMSs. Such a view is supported by
the insertions of His-tags and the BAD in many
loops of the lactose transport protein LacY that re-
sult in a protein active in proton motive force driven
lactose transport [13,14]. On the other hand, muta-
tions in the loops of the same protein and other
transporters have been described that a¡ect the sub-
strate speci¢city or activity of the transporters, sug-
gesting a role for loop regions in catalysis and a
de¢ned structure of the loop [15^18]. The CitS mol-
ecule contains four loops that are considerably lon-
ger than usually observed in bacterial secondary
transporters, a feature that is conserved throughout
the 2HCT family. It is likely that these loops play
some role in the structure and/or function of the
transporter. Insertion of the 10 kDa BAD was ac-
cepted at four out of ¢ve tested positions in these
loop regions, while the His-tag could be inserted in
both tested positions without destabilizing the mole-
cule. Only half of the six stable insertion mutants
had retained citrate transport activity.
The periplasmic loop between TMSs V and VI is
about 40 residues long and contains hydrophobic
stretch Vb that was originally predicted to be trans-
membrane (see Fig. 1) [7]. The stretch contains nine
conserved residues, including four Gly and two Pro,
and is one of the two most conserved regions of the
2HCT family. A His-tag could be inserted just down-
stream of the segment without loss of activity (Table
1, SH200) and the tagged protein could be puri¢ed
by Ni2-NTA a⁄nity chromatography, indicating
that the inserted His-tag is exposed to the water
phase. The data suggest that the region downstream
of the conserved stretch is a £exible loop structure.
The cytoplasmic loop between TMSs VI and VII is
about 30 residues long of which only two are con-
served (two Gly). The loop resembles somewhat the
large cytoplasmic loop that separates the NH2- and
COOH-terminal halves of the transporters of the ma-
jor facilitator superfamily even though there is no
evidence for structural similarity between transport-
ers of the two families [19]. The 10 kDa BAD was
inserted in the COOH-terminus (SB260) and the
NH2-terminus (SB239). Insertion at both positions
resulted in a stable and in vivo biotinylated chimera,
suggesting that the structure was not severely dis-
turbed. Remarkably, the insertion at position 239
inactivated the protein, while the chimera with the
BAD inserted at position 260 was active in citrate
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transport. It appears that the relevance of a loop for
catalysis cannot be evaluated from a single insertion
in the loop.
The loop between TMSs VIII and IX is about 25
residues long, contains no conserved residues and is
only moderately hydrophilic. We noted before that
the loop is strongly amphipathic when folded as an
K-helix [9], a feature that is conserved throughout the
members of the family. Possibly, this region forms a
surface helix, exposing its hydrophobic face towards
the membrane and its hydrophilic face towards the
cytoplasm. In SN328, three residues in the putative
amphipathic helix are mutated, which leaves the pro-
tein stable, but completely inactivates it (Table 1).
Insertion of the 10 kDa BAD at this position re-
sulted in rapid degradation of the protein, while in-
sertion of the much smaller His-tag left the protein
stable. The His-tagged protein could not be puri¢ed
by Ni2-NTA a⁄nity chromatography, suggesting
that the tag is folded in the structure of CitS. The
data suggest that the loop between TMSs VIII and
IX is very well structured and important to the func-
tion of CitS.
The most COOH-terminal cytoplasmic loop of
CitS is about 45 residues long and contains the sec-
ond well conserved region of the 2HCT family just in
front of TMS XI with seven and nine out of 21
identical and similar residues, respectively. Insertion
of the BAD at position 398, just in front of the con-
served region, inactivated the protein, but the protein
was stably expressed and biotinylated in vivo. Inser-
tion of the BAD 10 residues upstream in SB389 did
not inactivate the protein, but the BAD could not be
biotinylated in vivo, suggesting that the domain, at
least in part, was buried in the structure of the loop.
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